Shares of Teva Pharmaceuticals fall after US Patent Office invalidates two patents
August 24, 2016 at 17:40 PM EDT
Shares of Teva Pharmaceuticals fell as much as 6 percent on Wednesday after the U.S. Patent Office invalidated two of the company's patents.
